Specialty Overview

Best Hospitals for Pancreatic Cancer Treatment in Delhi NCR, India

35 surgical oncology hospitals in our India network are listed in Delhi NCR, accredited by JCI, NABH, NABL, ISO, with 17,362 beds combined.

35
Hospitals Listed
1
City
4.5
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the surgical oncology hospitals in our directory offering Pancreatic Cancer Treatment in Delhi NCR, India, including Apollo Hospitals, Medanta - The Medicity, Artemis Hospital, Fortis Memorial Research Institute and others. Each listing links through to the hospital's full profile page.

Ask us about pancreatic cancer treatment in Delhi NCR, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 35 accredited hospitals for Surgical Oncology in Delhi NCR, India

Starting from$1,000

🇮🇳 Apollo Hospitals

New Delhi, India 4.9 (1240 reviews) 1,000 beds
Why consider this hospital?
4.9/5 rating from 1240 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering pancreatic cancer treatment can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.9/5
Rating
1983
Established
1,000
Beds
New Delhi, India
Location
Medanta - The Medicity
Starting from$1,000

🇮🇳 Medanta - The Medicity

Gurgaon, India 4.9 (2150 reviews) 1,600 beds
Why consider this hospital?
4.9/5 rating from 2150 reviewsAccredited by JCI, NABH1,600 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering pancreatic cancer treatment can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.9/5
Rating
2009
Established
1,600
Beds
Gurgaon, India
Location
Artemis Hospital
Starting from$1,000

🇮🇳 Artemis Hospital

Gurgaon, India 4.9 (64 reviews) 750 beds
Why consider this hospital?
4.9/5 rating from 64 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering pancreatic cancer treatment can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.9/5
Rating
2007
Established
750
Beds
Gurgaon, India
Location
Fortis Memorial Research Institute
Starting from$1,000

🇮🇳 Fortis Memorial Research Institute

Gurgaon, India 4.8 (1100 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1100 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering pancreatic cancer treatment can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.8/5
Rating
1996
Established
1,000
Beds
Gurgaon, India
Location
Max Super Specialty Hospital
Starting from$1,000

🇮🇳 Max Super Specialty Hospital

New Delhi, India 4.8 (1300 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 1300 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
CardiacLiver Transplant
Accredited by JCI, NABH

Patients considering pancreatic cancer treatment can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.8/5
Rating
2000
Established
500
Beds
New Delhi, India
Location
All India Institute of Medical Sciences (AIIMS)
Starting from$1,000

🇮🇳 All India Institute of Medical Sciences (AIIMS)

New Delhi, India 4.7 (3500 reviews) 2,400 beds
Why consider this hospital?
4.7/5 rating from 3500 reviewsAccredited by NABH2,400 beds
Specialties & Accreditation
Multi-specialtyResearch
Accredited by NABH

Patients considering pancreatic cancer treatment can be cared for by All India Institute of Medical Sciences (AIIMS)'s care team in New Delhi, India, from initial consultation through recovery. All India Institute of Medical Sciences (AIIMS), accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.7/5
Rating
1956
Established
2,400
Beds
New Delhi, India
Location
CK Birla Hospital
Starting from$1,000

🇮🇳 CK Birla Hospital

Gurugram, Haryana, India 4.7 (162 reviews) 90 beds
Why consider this hospital?
4.7/5 rating from 162 reviewsAccredited by NABH90 beds
Specialties & Accreditation
Obstetrics & GynecologyOrthopedicsCardiac SciencesOncologyPediatrics
Accredited by NABH

Patients considering pancreatic cancer treatment can be cared for by CK Birla Hospital's care team in Gurugram, Haryana, India, from initial consultation through recovery. CK Birla Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.7/5
Rating
2017
Established
90
Beds
Gurugram, Haryana, India
Location
Centre for Sight
Starting from$1,000

🇮🇳 Centre for Sight

Safdarjung Enclave, New Delhi, India 4.7 (181 reviews) 30 beds
Why consider this hospital?
4.7/5 rating from 181 reviewsAccredited by NABH30 beds
Specialties & Accreditation
LASIK SurgeryRetina SurgeryCataract SurgeryGlaucomaCornea Transplant
Accredited by NABH

Patients considering pancreatic cancer treatment can be cared for by Centre for Sight's care team in Safdarjung Enclave, New Delhi, India, from initial consultation through recovery. Centre for Sight, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.7/5
Rating
1996
Established
30
Beds
Safdarjung Enclave, New Delhi, India
Location
Max Super Specialty Hospital, Gurgaon
Starting from$1,000

🇮🇳 Max Super Specialty Hospital, Gurgaon

Gurgaon, India 4.6 (95 reviews) 104 beds
Why consider this hospital?
4.6/5 rating from 95 reviewsAccredited by NABH, JCI104 beds
Specialties & Accreditation
Cardiac SciencesOncologyOrthopedicsNeurosciencesTransplant
Accredited by NABH, JCI

Patients considering pancreatic cancer treatment can be cared for by Max Super Specialty Hospital, Gurgaon's care team in Gurgaon, India, from initial consultation through recovery. Max Super Specialty Hospital, Gurgaon, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.6/5
Rating
2007
Established
104
Beds
Gurgaon, India
Location
Max Super Speciality Hospital, Patparganj
Starting from$1,000

🇮🇳 Max Super Speciality Hospital, Patparganj

Patparganj, New Delhi, India 4.6 (97 reviews) 400 beds
Why consider this hospital?
4.6/5 rating from 97 reviewsAccredited by NABH, JCI400 beds
Specialties & Accreditation
Cardiac SciencesOncologyOrthopedicsNeurosciencesTransplant
Accredited by NABH, JCI

Patients considering pancreatic cancer treatment can be cared for by Max Super Speciality Hospital, Patparganj's care team in Patparganj, New Delhi, India, from initial consultation through recovery. Max Super Speciality Hospital, Patparganj, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing pancreatic cancer treatment.

4.6/5
Rating
2005
Established
400
Beds
Patparganj, New Delhi, India
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Surgical Oncology is among its listed specialties and it is located in Delhi NCR, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Pancreatic Cancer Treatment in Delhi NCR, India?

Choosing the right hospital for pancreatic cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include surgical oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Pancreatic Cancer Treatment

Pancreatic cancer treatment encompasses a spectrum of interventions — from curative-intent Whipple procedures and distal pancreatectomies to advanced systemic therapies including FOLFIRINOX, gemcitabine-nab-paclitaxel combinations, and precision-targeted PARP inhibitors for BRCA-mutated tumors.

7–21 days (varies by treatment modality: 7–10 days for Whipple/pancreatectomy; shorter for chemotherapy initiation cycles)
Hospital Stay
4–8 weeks post-surgery for major resection; 2–3 weeks after chemotherapy cycle initiation, subject to oncologist clearance
Total Stay in Country (Fit-to-Fly)
20–25% 5-year survival for resectable (Stage I–II) disease; median overall survival of 12–18 months for locally advanced disease with multimodal therapy
Success Rate

Clinical Overview

  • Pancreatic cancer — most commonly pancreatic ductal adenocarcinoma (PDAC) — arises from the exocrine cells lining the pancreatic ducts and accounts for approximately 90% of all pancreatic malignancies.
  • Because the pancreas is a deeply retroperitoneal organ with rich lymphovascular proximity to the superior mesenteric artery (SMA), portal vein, and celiac axis, early-stage disease is largely asymptomatic, resulting in over 80% of cases being diagnosed at locally advanced (Stage III) or metastatic (Stage IV) stages.
  • Physiologically, tumor involvement disrupts both exocrine function — leading to malabsorption, steatorrhea, and significant weight loss — and endocrine function, frequently inducing new-onset diabetes mellitus.
Full details →

Who is a Candidate?

  • ELIGIBLE FOR SURGICAL RESECTION (Whipple / Distal Pancreatectomy / Total Pancreatectomy):

- Pathologically or radiologically confirmed pancreatic ductal adenocarcinoma, acinar cell carcinoma, or pancreatic neuroendocrine tumor (pNET)

Full details →

Treatment Options & Approaches

  • SURGICAL APPROACHES:

Recovery

  • PHASE 1 — PRE-ARRIVAL & REMOTE CONSULTATION (Weeks 1–2):

Risks to be aware of

  • Pancreatic cancer treatment carries a meaningful spectrum of procedural and oncologic risks that patients must understand transparently.
  • For the Whipple procedure (pancreaticoduodenectomy), the most clinically significant complication is Post-Operative Pancreatic Fistula (POPF), occurring in 10–25% of cases and classified Grade A (biochemical leak), B (requiring intervention), or C (life-threatening) per ISGPS criteria; Grade B/C fistulas may require percutaneous drain insertion, radiologic intervention, or re-operation.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive, white-glove medical travel coordination for international patients pursuing pancreatic cancer treatment in India or the UAE, covering every logistical need from first inquiry to departure.

Cost Range for Related Procedures

Cancer Surgery$4,000$15,000
Chemotherapy$1,000$4,000
Radiation Therapy$3,500$10,000
Get a personalised estimate with our cost calculator →

Common questions about Pancreatic Cancer Treatment

What is the cost of Pancreatic Cancer Treatment in India vs. the UAE?
The total cost of pancreatic cancer treatment varies by stage, treatment modality, and hospital tier. For a complete surgical episode (Whipple procedure or distal pancreatectomy including surgeon's fee, anesthesia, ICU care, private ward stay, pathology, and standard medications) at a JCI- or NABH-accredited hospital in India, the all-inclusive cost typically ranges from USD 6,000 to USD 18,000 — with robotic-assisted Whipple procedures and complex vascular reconstruction at the higher end. The same treatment at JCI- and DHA-licensed hospitals in Dubai or Abu Dhabi ranges from USD 15,000 to USD 40,000, reflecting premium infrastructure and higher operational costs in the UAE. For systemic chemotherapy-only programs (e.g., FOLFIRINOX or gemcitabine-nab-paclitaxel for locally advanced or metastatic disease), per-cycle costs in India range from USD 800–2,500 and in the UAE from USD 2,500–6,000 per cycle depending on the drug regimen. Targeted therapies (e.g., olaparib for BRCA-mutated cases) and NGS tumor profiling costs are additional. GAF Healthcare provides a personalized cost estimate within 48 hours of receiving the patient's medical records, with no hidden fees.
How long do I need to stay in the country before I am fit to fly home after Pancreatic Cancer Treatment?
The required in-country stay depends primarily on the treatment modality. For patients undergoing a Whipple procedure (pancreaticoduodenectomy) or distal pancreatectomy, the hospital stay is typically 7–14 days, followed by a mandatory post-discharge recovery period near the hospital for outpatient monitoring. Most pancreatic surgery patients are cleared as fit-to-fly at 4–6 weeks post-operatively, once the treating surgeon confirms: stable nutritional intake and tolerability of oral diet; no active drain, wound complication, or signs of fistula; adequate pain control on oral analgesics; and normal or acceptable post-operative imaging (CT at Week 3–4). Patients who undergo laparoscopic distal pancreatectomy (less invasive) may be cleared earlier, typically at 3–4 weeks. The total recommended in-country stay for surgical patients is therefore 5–8 weeks. For patients receiving chemotherapy initiation only (without surgery), the in-country stay is shorter — typically 2–3 weeks to complete the first cycle, assess tolerance, and receive oncology follow-up — before returning home to continue treatment locally. GAF Healthcare arranges a formal fit-to-fly assessment and provides the patient with a structured medical travel certificate, in-flight positioning guidelines, and LMWH (blood-clot prevention injection) instructions for long-haul flights, which are typically required for 5–7 days post-travel in post-surgical oncology patients.
What is the success rate of Pancreatic Cancer Treatment?
Success rates in pancreatic cancer treatment are stage-dependent and must be interpreted with clinical context. For surgically resected Stage I–II pancreatic ductal adenocarcinoma (PDAC) at high-volume centers (defined as >20 Whipple procedures annually), the 5-year overall survival rate is approximately 20–30%, with R0 (margin-negative) resection being the single most important prognostic factor. Median overall survival after resection followed by adjuvant modified FOLFIRINOX is 54 months (PRODIGE 24 trial), representing a major improvement over historical benchmarks. For borderline resectable disease treated with neoadjuvant FOLFIRINOX followed by surgery, 5-year survival rates of 25–30% are achievable in patients achieving a complete resection. For locally advanced (Stage III) unresectable PDAC, the median overall survival with current multimodal chemoradiation protocols is 12–20 months, with a subset of patients — particularly those with exceptional responses to FOLFIRINOX — becoming secondarily resectable and achieving long-term survival. For metastatic (Stage IV) PDAC, current systemic therapy achieves a median overall survival of 8–12 months with FOLFIRINOX or gemcitabine-nab-paclitaxel; however, molecularly selected subgroups fare significantly better — for example, BRCA1/2-mutated patients on maintenance olaparib achieve a median progression-free survival of 7.4 months versus 3.8 months on placebo (POLO trial), and MSI-H patients receiving pembrolizumab may achieve durable responses. GAF Healthcare partner centers in India and the UAE perform full molecular tumor profiling for every patient to identify all actionable targets, maximizing individualized treatment benefit.

How GAF Healthcare Assists in Choosing the Best Hospital for Pancreatic Cancer Treatment in Delhi NCR, India

Discover the Top Hospitals for Pancreatic Cancer Treatment in Delhi NCR, India

This page lists 35 accredited surgical oncology hospitals in Delhi NCR, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about pancreatic cancer treatment in Delhi NCR, India

How many surgical oncology hospitals are listed in Delhi NCR, India?
35 hospitals in our Delhi NCR, India directory are currently listed for surgical oncology including Pancreatic Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Surgical Oncology is among its listed specialties and it is located in Delhi NCR, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there surgical oncology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for pancreatic cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about pancreatic cancer treatment in Delhi NCR, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for pancreatic cancer treatment in Delhi NCR, India.

Contact us to report an inaccuracy on this page.